Cabot-Wellington Has Lowered Its Gilead Sciences (GILD) Position; Lonestar Resources US – Class A (LONE) Shorts Up By 245.26%

May 26, 2018 - By Louis Casey

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Lonestar Resources US Inc – Class A (NASDAQ:LONE) had an increase of 245.26% in short interest. LONE’s SI was 32,800 shares in May as released by FINRA. Its up 245.26% from 9,500 shares previously. With 56,600 avg volume, 1 days are for Lonestar Resources US Inc – Class A (NASDAQ:LONE)’s short sellers to cover LONE’s short positions. The SI to Lonestar Resources US Inc – Class A’s float is 0.84%. The stock decreased 4.67% or $0.32 during the last trading session, reaching $6.53. About 456,693 shares traded or 229.67% up from the average. Lonestar Resources US Inc. (NASDAQ:LONE) has 0.00% since May 26, 2017 and is . It has underperformed by 11.55% the S&P500.

Cabot-Wellington Llc decreased Gilead Sciences (GILD) stake by 4.03% reported in 2017Q4 SEC filing. Cabot-Wellington Llc sold 5,760 shares as Gilead Sciences (GILD)’s stock rose 1.93%. The Cabot-Wellington Llc holds 137,230 shares with $9.83M value, down from 142,990 last quarter. Gilead Sciences now has $87.61B valuation. The stock decreased 0.22% or $0.15 during the last trading session, reaching $67.38. About 3.96 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 26, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: which released: “Gilead: Novartis’s Kymriah Is Coming To America” on May 24, 2018, also with their article: “He helped Gilead score billions from HIV, hepatitis C drugs — now he’s building a cancer fighter” published on May 23, 2018, published: “Gilead: Where’s The Next Catalyst?” on May 18, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: and their article: “Analysts Show More Caution Toward Gilead’s Mystical Recovery” published on May 02, 2018 as well as‘s news article titled: “Gilead: I’m Thankful That I Sold” with publication date: May 07, 2018.

Since January 2, 2018, it had 0 buys, and 22 sales for $44.80 million activity. $2.37M worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Alton Gregg H. $3.61 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by MARTIN JOHN C. The insider Washington Robin L sold $401,566. $467,138 worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Cogan John Francis on Friday, March 16. Meyers James R sold $8.02M worth of stock. WILSON GAYLE E also sold $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It dived, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Quantbot Tech Lp invested in 0.11% or 16,487 shares. Moody Natl Bank Trust Division owns 9,013 shares. Westport Asset Mngmt Inc reported 0.86% in Gilead Sciences, Inc. (NASDAQ:GILD). Clear Harbor Asset Management Ltd Liability has invested 0.15% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Biltmore Wealth Mgmt Ltd Liability Com reported 0.32% stake. Cornerstone Advsr stated it has 5,164 shares or 0.25% of all its holdings. The Switzerland-based Credit Suisse Ag has invested 0.27% in Gilead Sciences, Inc. (NASDAQ:GILD). Reliance Tru Of Delaware stated it has 6,272 shares or 0.07% of all its holdings. 13,614 are owned by Davenport & Company Limited Liability. Kings Point Mngmt stated it has 400 shares. Mufg Americas Hldgs owns 180,786 shares. Nwq Inv Mngmt Ltd Liability invested in 484,957 shares. Mitchell Mcleod Pugh Williams Incorporated reported 0.56% in Gilead Sciences, Inc. (NASDAQ:GILD). Principal Financial Gp accumulated 0.18% or 2.80M shares. Intrust Bankshares Na owns 0.38% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 17,603 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, January 2. The stock has “Hold” rating by Needham on Tuesday, October 3. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Jefferies on Wednesday, October 4. BMO Capital Markets maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, February 7. BMO Capital Markets has “Hold” rating and $88.0 target. The company was maintained on Monday, September 21 by Cowen & Co. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, March 15 with “Hold” rating. Credit Suisse downgraded Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, September 5 to “Hold” rating. The firm earned “Neutral” rating on Friday, January 15 by Bank of America. The firm has “Buy” rating by William Blair given on Thursday, August 31. The rating was maintained by Maxim Group with “Buy” on Friday, February 12.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on July, 25. They expect $1.43 earnings per share, down 43.03% or $1.08 from last year’s $2.51 per share. GILD’s profit will be $1.86B for 11.78 P/E if the $1.43 EPS becomes a reality. After $1.37 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts 4.38% EPS growth.

Lonestar Resources US Inc., an independent gas and oil company, engages in the acquisition, development, and production of unconventional oil, natural gas liquids, and natural gas properties in the United States. The company has market cap of $160.88 million. The firm primarily focuses on Eagle Ford Shale properties in Texas counties. It currently has negative earnings. It also owns 28,655 net undeveloped acres in the Poplar West area of the Bakken Three Forks formation located in Roosevelt County, Montana.

More recent Lonestar Resources US Inc. (NASDAQ:LONE) news were published by: which released: “Lonestar Resources US’s (LONE) CEO Frank Bracken on Q1 2018 Results – Earnings Call Transcript” on May 14, 2018. Also published the news titled: “Lonestar Announces Increase In Borrowing Base To $190 Million” on May 24, 2018.‘s news article titled: “5 Top Energy Stocks to Buy Right Now” with publication date: May 23, 2018 was also an interesting one.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: